首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2092965

伴侶動物風險評估市場預測（2034 年）—按解決方案類型、動物類型、風險類型、技術、最終用戶和地區分類的全球分析

Companion Animal Risk Assessment Market Forecasts to 2034 - Global Analysis By Solution Type, Animal Type, Risk Type, Technology, End User and By Geography

出版日期: 2026年07月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球伴侶動物風險評估市場預計到 2026 年將達到 6 億美元，並在預測期內以 16.9% 的複合年成長率成長，到 2034 年將達到 21 億美元。

伴侶動物風險評估是指透過結構化的調查方法和數據驅動的分析，系統地評估可能影響伴侶動物的健康、行為、環境、營養和疾病相關風險。這包括識別、測量和確定風險因素的優先級，以支持預防醫學、臨床決策和長期健康管理。透過整合獸醫資訊、診斷結果和環境指標，伴侶動物風險評估能夠及早識別風險，從而支持改進護理計劃、提升動物福利和提供科學的獸醫干預措施。

重視預防醫學

隨著世界獸醫學向預防醫學轉型，對伴侶動物風險評估解決方案的需求顯著成長，這些方案能夠在臨床症狀出現之前識別潛在的健康問題。獸醫專業人士日益認知到，早期風險識別有助於採取乾預措施，從而改善治療效果並降低治療成本。寵物保險公司正在利用風險評估數據制定個人化的健康管理計畫並設定精準的保費。了解預防醫學益處的寵物飼主正在積極尋求基因檢測和健康篩檢服務。透過將風險評分納入常規健康檢查，預測性健康管理正變得越來越普及。

資料隱私問題

伴侶動物遺傳和健康數據的收集與分析引發了嚴重的隱私問題，威脅著市場成長。寵物飼主擔心，顯示遺傳疾病易感性的基因資訊可能會影響保險範圍和繁殖決策。涉及敏感動物健康資訊的資料外洩事件會削弱消費者對風險評估平台的信任。與人類健康數據相比，動物遺傳資料保護的法律規範仍然不夠完善。健全的資料安全措施和透明的知情同意流程對於應對這些隱私挑戰至關重要。

與保險公司合作

風險評估技術與寵物保險產品的融合為創新市場拓展提供了機會。基於風險的保費計算模型利用評估數據，提供根據動物個體健康狀況量身定做的個人化保費。與風險評估完成情況掛鉤的預防性護理獎勵，鼓勵飼主參與健康計畫。理賠預測模型可幫助保險公司識別高風險投保人並採取積極主動的干預措施。風險評估平台提供者與保險公司之間的合作，建構了一個綜合的健康管理生態系統，使動物、飼主和保險公司三方受益。

假陽性引起的焦慮

風險評估演算法可能產生假陽性預測，這會引起寵物飼主和獸醫的焦慮，並可能影響市場接受度。高估疾病風險會導致不必要的診斷測試和治療性介入，也會對飼主造成精神負擔。不同犬種和混種犬的基因資料庫不完整會降低預測的準確性。如果寵物主人知道有遺傳易感性卻無法採取預防措施，由此產生的心理負擔會讓人質疑這項服務的提案。鑑於這些擔憂，必須對風險的機率和不確定性程度進行詳盡的解釋。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了伴侶動物風險評估的普及，這主要歸因於寵物飼養量的增加以及人們對預防性健康資訊需求的上升。在疫情封鎖期間，人們鼓勵在線上購買基因檢測產品並在數位健康平台註冊。然而，獸醫診所的關閉暫時限制了人們獲得專家解讀檢測結果和後續服務的途徑。疫情過後，寵物飼養量的增加和人們健康意識的提高，推動了對風險評估基礎設施的持續投資。

在預測期內，健康風險評估平台細分市場預計將佔據最大的市場佔有率。

預計在預測期內，健康風險評估平台細分市場將佔據最大的市場佔有率，因為它能夠全面分析影響伴侶動物健康的臨床、生活方式和環境因素。健康風險評估平台匯總來自獸醫記錄、穿戴式裝置、營養記錄和活動監測器的數據，從而創建全面的風險概況。這些系統能夠識別可透過預防性干預措施減輕的風險因素，例如肥胖、牙科疾病和寄生蟲感染。與臨床管理軟體整合技術的進步使得在常規健康檢查期間進行無縫風險評估成為可能。領先的獸醫診斷公司正在將健康風險評估模組整合到其全面的健康檢查項目中。

在預測期內，狗類產品細分市場預計將呈現最高的複合年成長率。

在預測期內，犬類市場預計將呈現最高的成長率，這主要得益於寵物飼養量的增加、預防性獸醫保健支出的成長以及人們對早期疾病檢測意識的提高。人工智慧驅動的健康監測、基因篩檢和個人化風險評估工具的日益普及正在加速市場擴張。此外，犬類慢性病和老齡化相關疾病的高發生率也推動了對持續風險評估的需求，使得犬類市場成為伴侶動物風險評估市場中成長最快的類別。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其較高的寵物保險普及率和完善的獸醫診斷基礎設施，從而支持風險評估的普及。美國憑藉其龐大的消費者基因檢測市場和先進的獸醫專業服務，在市場中處於領先地位。加拿大則憑藉其先進的動物健康研究和資金雄厚的獸醫機構，為市場做出了貢獻。較高的可支配收入和重視預防醫學的文化正在推動消費者對風險評估服務的需求。碩騰（Zoetis）、IDEXX Laboratories 和瑪氏科學與診斷（Mars Science & Diagnostics）等領先企業在全部區域保持顯著的市場佔有率。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有量的快速成長以及人們對先進獸醫技術的日益了解。中國和日本是關鍵的成長市場，這主要得益於中產階級寵物擁有率的提高以及獸醫診斷能力的現代化。韓國和澳洲的高科技應用率很高，人們對寵物精準醫療的興趣日益濃厚。不斷擴大的寵物保險市場催生了對基於風險的承保工具的需求。該地區持續發展的生物技術產業正在推動國內基因組研究和風險模型開發。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Zoetis Inc.
IDEXX Laboratories, Inc.
Antech Diagnostics
Mars Science & Diagnostics
Basepaws
Wisdom Panel
Embark Veterinary, Inc.
Neogen Corporation
Merck Animal Health
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Virbac SA
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Heska Corporation
Pethealth Inc.
Trupanion, Inc.

簡介目錄圖表

Product Code: SMRC38134

According to Stratistics MRC, the Global Companion Animal Risk Assessment Market is accounted for $0.6 billion in 2026 and is expected to reach $2.1 billion by 2034 growing at a CAGR of 16.9% during the forecast period. Companion Animal Risk Assessment refers to the systematic evaluation of potential health, behavioral, environmental, nutritional, and disease-related risks affecting companion animals through structured assessment methodologies and data-driven analysis. It involves identifying, measuring, and prioritizing risk factors to support preventive care, clinical decision-making, and long-term health management. By integrating veterinary information, diagnostic findings, and environmental indicators, companion animal risk assessment enables early risk identification, improves care planning, enhances animal welfare, and supports informed veterinary interventions.

Market Dynamics:

Driver:

Preventive care emphasis

The global shift toward preventive veterinary care is driving substantial demand for companion animal risk assessment solutions that identify potential health issues before clinical symptoms develop. Veterinary professionals increasingly recognize that early risk identification enables interventions that improve outcomes and reduce treatment costs. Pet insurance providers leverage risk assessment data to develop personalized wellness plans and accurate premium pricing. End-user pet owners educated about preventive care benefits actively seek genetic testing and health screening services. The integration of risk scores into routine wellness examinations normalizes predictive health management.

Restraint:

Data privacy concerns

The collection and analysis of genetic and health data for companion animals raises significant privacy concerns that threaten market growth. Pet owners worry that genetic information revealing predispositions to hereditary diseases could affect insurance coverage or breeding decisions. Data breaches involving sensitive animal health information compromise consumer trust in risk assessment platforms. Regulatory frameworks for animal genetic data protection remain underdeveloped compared to human health data standards. These privacy challenges necessitate robust data security measures and transparent consent processes.

Opportunity:

Insurance integration

The convergence of risk assessment technology with pet insurance products presents transformative market expansion opportunities. Risk-based insurance pricing models use assessment data to offer personalized premiums reflecting individual animal health profiles. Preventive care incentives tied to risk assessment completion encourage pet owner engagement with wellness programs. Claims prediction models help insurers identify high-risk policyholders for proactive intervention. Partnerships between risk assessment platform providers and insurance companies create integrated health management ecosystems that benefit animals, owners, and insurers.

Threat:

False positive anxiety

The potential for risk assessment algorithms to generate false positive predictions creates anxiety among pet owners and veterinarians that threatens market acceptance. Overprediction of disease risk leads to unnecessary diagnostic testing, therapeutic interventions, and owner distress. Incomplete genetic databases for diverse breeds and mixed-breed animals reduce prediction accuracy. The psychological burden of knowing genetic predispositions without available preventive measures challenges the value proposition. These concerns necessitate careful communication of risk probabilities and uncertainty ranges.

Covid-19 Impact:

The COVID-19 pandemic accelerated companion animal risk assessment adoption as increased pet ownership created demand for preventive health information. Lockdown periods drove online genetic testing purchases and digital health platform registrations. However, veterinary clinic restrictions temporarily limited professional interpretation and follow-up services. Post-pandemic, the enlarged pet population and heightened health awareness support continued investment in risk assessment infrastructure.

The health risk assessment platforms segment is expected to be the largest during the forecast period

The health risk assessment platforms segment is expected to account for the largest market share during the forecast period, due to its comprehensive analysis of clinical, lifestyle, and environmental factors affecting companion animal health. Health risk platforms aggregate data from veterinary records, wearable devices, nutrition logs, and activity monitors to generate holistic risk profiles. The systems identify modifiable risk factors, including obesity, dental disease, and parasitic exposure, that respond to preventive interventions. Growing integration with practice management software enables seamless risk assessment during routine wellness visits. Major veterinary diagnostic companies embed health risk modules into comprehensive wellness screening panels.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, driven by increasing pet ownership, rising expenditure on preventive veterinary care, and growing awareness of early disease detection. Greater adoption of AI-enabled health monitoring, genetic screening, and personalized risk assessment tools is accelerating market expansion. Additionally, the high prevalence of chronic conditions and age-related disorders in dogs is boosting demand for continuous risk evaluation, positioning the dogs segment as the fastest-growing category in the Companion Animal Risk Assessment Market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high pet insurance penetration and advanced veterinary diagnostic infrastructure supporting risk assessment adoption. The United States leads with extensive direct-to-consumer genetic testing markets and sophisticated veterinary specialty services. Canada contributes through its progressive animal health research and well-funded veterinary institutions. High disposable incomes and cultural emphasis on preventive healthcare drive consumer demand for risk assessment services. Major companies, including Zoetis, IDEXX Laboratories, and Mars Science & Diagnostics, maintain significant market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding pet ownership and increasing awareness of advanced veterinary care options. China and Japan represent major growth markets with growing middle-class pet ownership and the modernization of veterinary diagnostic capabilities. South Korea and Australia demonstrate high technology adoption rates and interest in precision pet health. Growing pet insurance markets create demand for risk-based underwriting tools. The region's expanding biotechnology sector supports indigenous genomic research and the development of risk models.

Key players in the market

Some of the key players in Companion Animal Risk Assessment Market include Zoetis Inc., IDEXX Laboratories, Inc., Antech Diagnostics, Mars Science & Diagnostics, Basepaws, Wisdom Panel, Embark Veterinary, Inc., Neogen Corporation, Merck Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Virbac S.A., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Pethealth Inc. and Trupanion, Inc..

Key Developments:

In June 2026, Elanco Animal Health Incorporated launched an artificial intelligence-powered genetic risk assessment platform analyzing over two hundred disease markers across canine and feline breeds for personalized preventive care recommendations.

In May 2026, Neogen Corporation secured a major contract deploying health risk assessment platforms across European pet insurance networks for dynamic premium pricing and preventive care incentive programs.

In April 2026, Pethealth Inc. introduced a next-generation wearable sensor integration platform combining activity monitoring with behavioral pattern analysis for early detection of health deterioration in companion animals.

In March 2026, Boehringer Ingelheim Animal Health expanded its disease prediction software to include environmental risk factor modeling, enabling location-based recommendations for parasite prevention and vaccination schedules.

Solution Types Covered:

Health Risk Assessment Platforms
Genetic Risk Assessment Solutions
Disease Prediction Software
Behavioral Risk Assessment Systems
Insurance Risk Analytics
Preventive Care Assessment Platforms
AI-Based Risk Intelligence Solutions

Animal Types Covered:

Dogs
Cats
Birds
Small Mammals
Reptiles
Others

Risk Types Covered:

Chronic Disease Risk
Genetic Disorder Risk
Obesity Risk
Infectious Disease Risk
Behavioral Risk
Environmental Risk

Technologies Covered:

Artificial Intelligence
Machine Learning
Genomic Analytics
Big Data Analytics
Cloud Computing
Wearable Sensor Technology

End Users Covered:

Veterinary Hospitals
Veterinary Clinics
Pet Insurance Providers
Animal Diagnostic Laboratories
Research Institutes
Pet Owners

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Risk Assessment Market, By Solution Type

5.1 Health Risk Assessment Platforms
5.2 Genetic Risk Assessment Solutions
5.3 Disease Prediction Software
5.4 Behavioral Risk Assessment Systems
5.5 Insurance Risk Analytics
5.6 Preventive Care Assessment Platforms
5.7 AI-Based Risk Intelligence Solutions

6 Global Companion Animal Risk Assessment Market, By Animal Type

6.1 Dogs
6.2 Cats
6.3 Birds
6.4 Small Mammals
6.5 Reptiles
6.6 Others

7 Global Companion Animal Risk Assessment Market, By Risk Type

7.1 Chronic Disease Risk
7.2 Genetic Disorder Risk
7.3 Obesity Risk
7.4 Infectious Disease Risk
7.5 Behavioral Risk
7.6 Environmental Risk

8 Global Companion Animal Risk Assessment Market, By Technology

8.1 Artificial Intelligence
8.2 Machine Learning
8.3 Genomic Analytics
8.4 Big Data Analytics
8.5 Cloud Computing
8.6 Wearable Sensor Technology

9 Global Companion Animal Risk Assessment Market, By End User

9.1 Veterinary Hospitals
9.2 Veterinary Clinics
9.3 Pet Insurance Providers
9.4 Animal Diagnostic Laboratories
9.5 Research Institutes
9.6 Pet Owners

10 Global Companion Animal Risk Assessment Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Zoetis Inc.
13.2 IDEXX Laboratories, Inc.
13.3 Antech Diagnostics
13.4 Mars Science & Diagnostics
13.5 Basepaws
13.6 Wisdom Panel
13.7 Embark Veterinary, Inc.
13.8 Neogen Corporation
13.9 Merck Animal Health
13.10 Boehringer Ingelheim Animal Health
13.11 Ceva Sante Animale
13.12 Virbac S.A.
13.13 Dechra Pharmaceuticals PLC
13.14 Elanco Animal Health Incorporated
13.15 Heska Corporation
13.16 Pethealth Inc.
13.17 Trupanion, Inc.

簡介目錄圖表

List of Tables

Table 1 Global Companion Animal Risk Assessment Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Companion Animal Risk Assessment Market Outlook, By Solution Type (2023-2034) ($MN)
Table 3 Global Companion Animal Risk Assessment Market Outlook, By Health Risk Assessment Platforms (2023-2034) ($MN)
Table 4 Global Companion Animal Risk Assessment Market Outlook, By Genetic Risk Assessment Solutions (2023-2034) ($MN)
Table 5 Global Companion Animal Risk Assessment Market Outlook, By Disease Prediction Software (2023-2034) ($MN)
Table 6 Global Companion Animal Risk Assessment Market Outlook, By Behavioral Risk Assessment Systems (2023-2034) ($MN)
Table 7 Global Companion Animal Risk Assessment Market Outlook, By Insurance Risk Analytics (2023-2034) ($MN)
Table 8 Global Companion Animal Risk Assessment Market Outlook, By Preventive Care Assessment Platforms (2023-2034) ($MN)
Table 9 Global Companion Animal Risk Assessment Market Outlook, By AI-Based Risk Intelligence Solutions (2023-2034) ($MN)
Table 10 Global Companion Animal Risk Assessment Market Outlook, By Animal Type (2023-2034) ($MN)
Table 11 Global Companion Animal Risk Assessment Market Outlook, By Dogs (2023-2034) ($MN)
Table 12 Global Companion Animal Risk Assessment Market Outlook, By Cats (2023-2034) ($MN)
Table 13 Global Companion Animal Risk Assessment Market Outlook, By Birds (2023-2034) ($MN)
Table 14 Global Companion Animal Risk Assessment Market Outlook, By Small Mammals (2023-2034) ($MN)
Table 15 Global Companion Animal Risk Assessment Market Outlook, By Reptiles (2023-2034) ($MN)
Table 16 Global Companion Animal Risk Assessment Market Outlook, By Others (2023-2034) ($MN)
Table 17 Global Companion Animal Risk Assessment Market Outlook, By Risk Type (2023-2034) ($MN)
Table 18 Global Companion Animal Risk Assessment Market Outlook, By Chronic Disease Risk (2023-2034) ($MN)
Table 19 Global Companion Animal Risk Assessment Market Outlook, By Genetic Disorder Risk (2023-2034) ($MN)
Table 20 Global Companion Animal Risk Assessment Market Outlook, By Obesity Risk (2023-2034) ($MN)
Table 21 Global Companion Animal Risk Assessment Market Outlook, By Infectious Disease Risk (2023-2034) ($MN)
Table 22 Global Companion Animal Risk Assessment Market Outlook, By Behavioral Risk (2023-2034) ($MN)
Table 23 Global Companion Animal Risk Assessment Market Outlook, By Environmental Risk (2023-2034) ($MN)
Table 24 Global Companion Animal Risk Assessment Market Outlook, By Technology (2023-2034) ($MN)
Table 25 Global Companion Animal Risk Assessment Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 26 Global Companion Animal Risk Assessment Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 27 Global Companion Animal Risk Assessment Market Outlook, By Genomic Analytics (2023-2034) ($MN)
Table 28 Global Companion Animal Risk Assessment Market Outlook, By Big Data Analytics (2023-2034) ($MN)
Table 29 Global Companion Animal Risk Assessment Market Outlook, By Cloud Computing (2023-2034) ($MN)
Table 30 Global Companion Animal Risk Assessment Market Outlook, By Wearable Sensor Technology (2023-2034) ($MN)
Table 31 Global Companion Animal Risk Assessment Market Outlook, By End User (2023-2034) ($MN)
Table 32 Global Companion Animal Risk Assessment Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
Table 33 Global Companion Animal Risk Assessment Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
Table 34 Global Companion Animal Risk Assessment Market Outlook, By Pet Insurance Providers (2023-2034) ($MN)
Table 35 Global Companion Animal Risk Assessment Market Outlook, By Animal Diagnostic Laboratories (2023-2034) ($MN)
Table 36 Global Companion Animal Risk Assessment Market Outlook, By Research Institutes (2023-2034) ($MN)
Table 37 Global Companion Animal Risk Assessment Market Outlook, By Pet Owners (2023-2034) ($MN)